Literature DB >> 12031708

Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant.

Toshihisa Nagatomo1, Craig T January, Bin Ye, Haruhiko Abe, Yasuhide Nakashima, Jonathan C Makielski.   

Abstract

OBJECTIVE: For the congenital long QT (LQT) syndrome involving mutations of the cardiac sodium channel gene SCN5A, LQT3, the initiation of sudden cardiac death tends to be bradycardia- or pause-dependent, contrary to other LQT syndromes that tend to be adrenergic dependent. Enhanced shortening of the prolonged QT interval with increased heart rate has been reported in LQT3 patients. We hypothesized that the rate-dependent shortening of the QT interval may be attributed to the kinetic properties of inactivation the late sodium current (I(Na)) in LQT3.
METHODS: The deltaKPQ mutant of the human heart voltage-gated sodium channel alpha-subunit was stably transfected into a mammalian cell line (HEK293). I(Na) was recorded using a whole-cell patch-clamp technique.
RESULTS: A train of 50 depolarizing pulses or a train of 50 ventricular action potential waveforms was applied with different interpulse durations. Peak I(Na) for the 50th pulse compared with that of I(Na) in the first pulse was decreased <2% for interpulse durations as short as 20 ms, but late I(Na) amplitude measured at the end of the pulse was decreased 95, 78, 68, 56 and 47% with 1000, 500, 200, 100, 20 ms interpulse intervals, respectively. Using the action potential waveform a similar rate-dependent reduction of late I(Na) was found with minimal reduction of peak I(Na).
CONCLUSIONS: Late I(Na) amplitude in the deltaKPQ mutation is strongly rate dependent. Rate-dependent reductions of late I(Na) may cause shortening the QT interval at higher rates. This provides a mechanism correlating the genotype with the clinical phenotype, and provides a rationale for the effectiveness of pacemaker therapy in LQT3 patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031708     DOI: 10.1016/s0008-6363(02)00265-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  18 in total

1.  Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes.

Authors:  Sandro L Yong; Ying Ni; Teng Zhang; David J Tester; Michael J Ackerman; Qing K Wang
Journal:  Biochem Biophys Res Commun       Date:  2006-11-14       Impact factor: 3.575

2.  The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current.

Authors:  Jianding Cheng; David J Tester; Bi-Hua Tan; Carmen R Valdivia; Stacie Kroboth; Bin Ye; Craig T January; Michael J Ackerman; Jonathan C Makielski
Journal:  Physiol Genomics       Date:  2011-03-08       Impact factor: 3.107

3.  Late I(Na) in the Heart: Physiology, Pathology, and Pathways.

Authors:  Jonathan C Makielski; John W Kyle
Journal:  Circulation       Date:  2015-07-17       Impact factor: 29.690

4.  QT Dynamics During Exercise in Asymptomatic Children with Long QT Syndrome Type 3.

Authors:  Kazuhiro Takahashi; Taisuke Nabeshima; Mami Nakayashiro; Hitoshi Ganaha
Journal:  Pediatr Cardiol       Date:  2016-02-26       Impact factor: 1.655

5.  Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.

Authors:  Lin Wu; Jihua Ma; Hong Li; Chao Wang; Eleonora Grandi; Peihua Zhang; Antao Luo; Donald M Bers; John C Shryock; Luiz Belardinelli
Journal:  Circulation       Date:  2011-04-11       Impact factor: 29.690

6.  Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.

Authors:  Géza Berecki; Jan G Zegers; Zahurul A Bhuiyan; Arie O Verkerk; Ronald Wilders; Antoni C G van Ginneken
Journal:  J Physiol       Date:  2005-10-27       Impact factor: 5.182

7.  Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.

Authors:  Elizabeth A Schroder; Don E Burgess; Cody L Manning; Yihua Zhao; Arthur J Moss; Abhijit Patwardhan; Claude S Elayi; Karyn A Esser; Brian P Delisle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-24       Impact factor: 4.733

8.  Using computational modeling to predict arrhythmogenesis and antiarrhythmic therapy.

Authors:  Jonathan D Moreno; Colleen E Clancy
Journal:  Drug Discov Today Dis Models       Date:  2009

9.  Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.

Authors:  Larissa Fabritz; Dierk Damke; Markus Emmerich; Susann G Kaufmann; Kathrin Theis; Andreas Blana; Lisa Fortmüller; Sandra Laakmann; Sven Hermann; Elena Aleynichenko; Johannes Steinfurt; Daniela Volkery; Burkhard Riemann; Uwe Kirchhefer; Michael R Franz; Günter Breithardt; Edward Carmeliet; Michael Schäfers; Sebastian K G Maier; Peter Carmeliet; Paulus Kirchhof
Journal:  Cardiovasc Res       Date:  2010-01-28       Impact factor: 10.787

10.  Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.

Authors:  Xiao-Li Tian; Sandro L Yong; Xiaoping Wan; Ling Wu; Mina K Chung; Patrick J Tchou; David S Rosenbaum; David R Van Wagoner; Glenn E Kirsch; Qing Wang
Journal:  Cardiovasc Res       Date:  2004-02-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.